Has anyone else experienced a BCOR mutation with CLL and AML?
While the search results don't specifically mention BCOR mutations, it's worth noting that gene mutations are quite common in leukemia. More than 80 percent of people with CLL have detectable gene changes, and AML cells also frequently contain various mutations.
Show Full Answer
Has anyone else experienced a BCOR mutation with CLL and AML?
While the search results don't specifically mention BCOR mutations, it's worth noting that gene mutations are quite common in leukemia. More than 80 percent of people with CLL have detectable gene changes, and AML cells also frequently contain various mutations.
It's great that you're in remission and that Tibsovo is working for your IDH1 mutation. Tibsovo is specifically designed for people with AML who have an IDH1 gene mutation, and it can be used alone or with chemotherapy.
Since BCOR mutations aren't covered in the available information, it would be helpful to discuss with your healthcare team what this specific mutation means for your treatment plan and prognosis. They can provide personalized guidance based on your unique situation.
You might also consider posting about your BCOR mutation experience in the community forums, as connecting with other members who may have similar mutations could provide valuable insights and support.
December 20, 2025